Learn more about Peter Attia’s digital program
Avoiding Injury Part I: Eccentric Strength
Accidental injury is among the leading causes of death in the developed world, and even when an injury itself is not directly responsible for ending one’s life, the associated debilitation can hasten the onset and progression of other health concerns.
Why do we lose muscle strength with age?
Researchers have explored numerous contributors to loss of muscle strength with age, and it appears to boil down to two major factors: muscle quality and neuromuscular innervation.
The metabolic benefits of exercise & muscle mass
This video clip is from episode #205 – Energy balance, nutrition, & building muscle with Layne Norton, Ph.D. (Pt.2), originally released…
The difference between maximum aerobic capacity and efficiency
This video clip is from #151 – Alex Hutchinson, Ph.D.: Translating the science of endurance and extreme human performance, originally…
Breaking down VO2 max: Definition, history, why it plateaus, and whether it really matters
This video clip is from #151 – Alex Hutchinson, Ph.D.: Translating the science of endurance and extreme human performance, originally…
#206 – Exercising for longevity: strength, stability, zone 2, zone 5, and more
“We can do zone 2 our entire lives; we can do it safely, and it just yields enormous dividends.” —Peter Attia
Fasting & protein: the impact of fasting on muscle mass
This video clip is from Ask Me Anything (AMA) #32 — Exercise, squats, deadlifts, BFR, and TRT, originally released on…
Dispelling myths that excess protein intake increases cancer risk
This video clip is from episode #205 – Energy balance, nutrition, & building muscle with Layne Norton, Ph.D. (Pt.2), originally…
#205 – Energy balance, nutrition, & building muscle | Layne Norton, Ph.D. (Pt.2)
“Lean body mass is inversely proportional to your risk of mortality after age 50.” —Layne Norton
#202 – Peter on nutrition, disease prevention, sleep, and more — looking back on the last 100 episodes
“I really think that in 10 years we’re going to basically be using designer-based immunotherapies to eradicate most solid organ metastatic cancers.” —Peter Attia